A systematic review and meta-analysis of the safety and efficacy of anti-thymocyte globulin combined with eltrombopag in the treatment of severe aplastic anemia

Background: When it comes to the treatment of aplastic anemia fever, Guidelines for Aplastic Anemia regards Anti-thymocyte globulin (ATG) combined with eltrombopag as standard immunosuppressive plan, and ATG is main mode treat severe anemia. A large number prospective studies clinical trials have confirmed application value in Although brings satisfactory results, safety long-term use still unclear. Therefore, more trial are needed verify its safety.